Preliminary evidence for neuronal damage in cortical grey matter and normal appearing white matter in short duration relapsing-remitting multiple sclerosis: A quantitative MR spectroscopic imaging study

Journal of Neurology

Volumn 248, Issue 2, 2001, Pages 131-138

  Kapeller, Peter ^a,b   McLean, Mary A ^a   Griffin, Colette M ^a   Chard, Declan ^a   Parker, Geoff J M ^a   Barker, Gareth J ^a   Thompson, Alan J ^a   Miller, David H ^a,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF GRAZ   (Austria)

^c EPILEPSY SOCIETY   (United Kingdom)

Author keywords

1H Magnetic resonance spectroscopy; Multiple sclerosis; N acetyl aspartate; Neuronal loss

Indexed keywords

INOSITOL; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE DURATION; FEMALE; FOLLOW UP; GRAY MATTER; HUMAN; IMAGE ANALYSIS; MALE; MULTIPLE SCLEROSIS; NERVE CELL LESION; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RELAPSE; REMISSION; WHITE MATTER;

ADULT; ASPARTIC ACID; BRAIN; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NERVE DEGENERATION; TIME FACTORS;

EID: 0035077346     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004150170248     Document Type: Article

References (46)

1. Histologie de la sclerose en plaques
2. Axonal damage in acute multiple sclerosis lesions
3. Axonal transection in the lesions of multiple sclerosis
4. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis
5. Cortical lesions in multiple sclerosis
6. Assessment of MRI criteria for a diagnosis of MS
7. Sensitivity and reproducibility of fast FLAIR, FSE, and TGSE sequences for the MRI assessment of brain lesion load in multiple sclerosis. A preliminary study
8. The distribution of plaques in the cerebrum in multiple sclerosis
9. The neuropathology of multiple sclerosis
10. Immunocytochemical localisation of N-acetyl-aspartate with monoclonal antibodies
11. Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: Assessment of the load of disease
12. Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy
13. 1-H-magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal appearing white matter in multiple sclerosis
14. Imaging axonal damage of normal appearing white matter in multiple sclerosis
15. Serial proton magnetic resonance spectroscopic imaging, contrast enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis
16. Regional metabolite concentrations in human brain as determined by quantitative localised proton MRS
17. In vivo spectroscopic quantification of the N-acetyl moiety, creatine, and choline from large volumes of brain gray and white matter: Effects of normal ageing
18. Proton MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis
19. Estimation of metabolite concentrations from localised in vivo proton NMR spectra
20. Automated production of quantitative metabolite maps from short echo time 1-H-CSI of the brain
21. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells
22. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
23. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
24. Statistical parametric maps in functional imaging: A general linear approach
25. Normalisation of quantitative metabolite maps
26. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions
27. Chemical pathology of acute demyelinating lesions and its correlation with disability
28. The 5 year risk of MS after optic neuritis. Experience of the optic neuritis treatment trial
29. The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10 year follow up
30. Neuronal damage in T1-hypointense multiple sclerosis lesions demonstrated in vivo using proton magnetic resonance spectroscopy
31. Axonal loss in multiple sclerosis lesions: Magnetic resonance imaging insights into substrates of disability
32. Inflammatory CNS demyelination: Histopathologic correlation with in vivo quantitative proton MR spectroscopy
33. Magnetic resonance spectroscopy of multiple sclerosis: In vivo detection of myelin breakdown products
34. An MR study of lesion heterogeneity in patients with secondary progressive MS: Correlation between metabolic concentration, T1 relaxation time and appearance on T1 weighted MRI
35. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types
36. Myo-inositol: A newly identified nonnitrogenous osmoregulatory molecule in mammalian brain
37. Osmoregulatory changes in myo-inositol content and Na/myo-inositol cotransport in rat cortical astrocytes
38. Glutamine, myo-inositol, and organic brain osmolytes after portocaval anastomosis in the rat: Implications for ammonia-induced brain edema
39. 1H-MRSI of normal appearing white matter in multiple sclerosis
40. A review of chemical issues in 1-H-NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline
41. In vivo evidence for axonal dysfunction remote from focal cerebral demyelination of the type seen in multiple sclerosis
42. 1H magnetic resonance spectroscopy of normal appearing white matter in primary progressive multiple sclerosis
43. A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis
44. 1H Spectroscopic imaging at 4.1 T
45. The role of magnetic resonance techniques in understanding and managing multiple sclerosis
46. Attention impairment in recently diagnosed multiple sclerosis